Winston & Strawn LLP advises a diverse client base consisting of pharmaceuticals, biologics and medical devices producers on matters ranging from patent, product liability and broader commercial litigation, to M&As and private equity investments in the sector. Leading the team is Washington DC’s Reed Stephens, a specialist in FCA and Anti-Kickback proceedings, and with further expertise in Medicare and Medicaid reimbursement proceedings. Chicago-based George Lombardi offers extensive experience litigating patent disputes. May 2023 saw the practice reinforced by the arrival of a three-partner group from Reed Smith LLP, with government contracts lawyers Lawrence Block, Elizabeth Leavy and Lawrence Sher arriving in the capital.
Key clients
- Abbott Laboratories
- Alphatec Holdings
- Bayer
- Cresco Labs
- Corning Incorporated
- Estrella Biopharma, Inc.
- Fresenius Kabi USA
- Hikma Pharmaceuticals
- Intuitive Surgical
- Lupin Limited
- MSN Laboratories
- Novartis Pharma AG
- Otsuka America Pharmaceutical
- Pfizer
- Polpharma
- Sandoz Inc.
- Sun Pharmaceutical Industries, Ltd.
- Teva North America
Work highlights
- Represented Corning in a month-long patent infringement and trade secrets trial related to cell-culturing technology.
- Representing Hikma Pharmaceuticals in opioid litigation brought by the state of Arkansas by successfully arguing failure to state a claim against our client.
- Represented a MIT professor against false research misconduct charges, publicly clearing his name in connection with an internal investigation that lasted more than three years.
Practice head
The lawyer(s) leading their teams.
Reed Stephens